Literature DB >> 4108932

Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions.

J J McSharry, R W Compans, P W Choppin.   

Abstract

The identity of the glycoprotein of vesicular stomatitis virus (VSV) as the spike protein has been confirmed by the removal of the spikes with a protease from Streptomyces griseus, leaving bullet-shaped particles bounded by a smooth membrane. This treatment removes the glycoprotein but does not affect the other virion proteins, apparently because they are protected from the enzyme by the lipids in the viral membrane. The proteins of phenotypically mixed, bullet-shaped virions produced by cells mixedly infected with VSV and the parainfluenza virus simian virus 5 (SV5) have been analyzed by polyacrylamide gel electrophoresis. These virions contain all the VSV proteins plus the two SV5 spike proteins, both of which are glycoproteins. The finding of the SV5 spike glycoproteins on virions with the typical morphology of VSV indicates that there is not a stringent requirement that only the VSV glycoprotein can be used to form the bullet-shaped virion. On the other hand, the SV5 nucleocapsid protein and the major non-spike protein of the SV5 envelope were not detected in the phenotypically mixed virions, and this suggests that a specific interaction between the VSV nucleocapsid and regions of the cell membrane which contain the nonglycosylated VSV envelope protein is necessary for assembly of the bullet-shaped virion.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4108932      PMCID: PMC376253     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Concentration and purification of vesicular stomatitis virus by polyethylene glycol "precipitation".

Authors:  J McSharry; R Benzinger
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

2.  The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis.

Authors:  L A Caliguiri; H D Klenk; P W Choppin
Journal:  Virology       Date:  1969-11       Impact factor: 3.616

3.  Proteins of vesicular stomatitis virus. I. Polyacrylamide gel analysis of viral antigens.

Authors:  C Y Kang; L Prevec
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

4.  Chemical composition of the parainfluenza virus SV5.

Authors:  H D Klenk; P W Choppin
Journal:  Virology       Date:  1969-01       Impact factor: 3.616

5.  The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12.

Authors:  J V Maizel; D O White; M D Scharff
Journal:  Virology       Date:  1968-09       Impact factor: 3.616

6.  Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity.

Authors:  P W Choppin
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

7.  Biophysical studies of vesicular stomatitis virus.

Authors:  R M McCombs; M B Melnick; J P Brunschwig
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

8.  Structural proteins of vesicular stomatitis viruses.

Authors:  R R Wagner; T A Schnaitman; R M Snyder
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

9.  Protein composition of the structural components of vesicular stomatitis virus.

Authors:  R R Wagner; T C Schnaitman; R M Snyder; C A Schnaitman
Journal:  J Virol       Date:  1969-06       Impact factor: 5.103

10.  Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis.

Authors:  R R Wagner; R M Snyder; S Yamazaki
Journal:  J Virol       Date:  1970-05       Impact factor: 5.103

View more
  57 in total

1.  Cellular adsorption function of the sialoglycoprotein of vesicular stomatitis virus and its neuraminic acid.

Authors:  R H Schloemer; R R Wagner
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  Association of vesicular stomatitis virus glycoprotein with virion membrane: characterization of the lipophilic tail fragment.

Authors:  R H Schloemer; R R Wagner
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

3.  Proteins of Epstein-Barr Virus. II. Electrophoretic analysis of the polypeptides of the nucleocapsid and the glucosamine- and polysaccharide-containing components of enveloped virus.

Authors:  M Dolyniuk; E Wolff; E Kieff
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

4.  Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components.

Authors:  D H Bishop; P Repik; J F Obijeski; N F Moore; R R Wagner
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

5.  Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus.

Authors:  D M Knipe; D Baltimore; H F Lodish
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

6.  Membrane assembly in vitro: synthesis, glycosylation, and asymmetric insertion of a transmembrane protein.

Authors:  F N Katz; J E Rothman; V R Lingappa; G Blobel; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

7.  Role of heterologous and homologous glycoproteins in phenotypic mixing between Sendai virus and vesicular stomatitis virus.

Authors:  K Metsikkö; H Garoff
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Dissociation of vesicular stomatitis virus and relation of the virion proteins to the viral transcriptase.

Authors:  D H Bishop; P Roy
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

9.  Effect of vesicular stomatitis virus infection on the histocompatibility antigen of L cells.

Authors:  T T Hecht; D F Summers
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

10.  Structure of the membrane protein of influenza virus. I. Isolation and characterization of cyanogen bromide cleavage products.

Authors:  B H Robertson; A S Bhown; R W Compans; J C Bennett
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.